[PDF][PDF] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramirez, E Pericuesta… - International Journal …, 2007 - researchgate.net
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies.

MA Ramírez, E Pericuesta… - The International …, 2007 - europepmc.org
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramirez, E Pericuesta… - … International Journal of …, 2007 - ijdb.ehu.eus
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MÁ Ramírez, E Pericuesta Camacho… - Departamento de …, 2007 - digital.csic.es
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies.

MA Ramírez, E Pericuesta… - International …, 2007 - search.ebscohost.com
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

[引用][C] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramirez, E Pericuesta… - … International Journal of …, 2007 - cir.nii.ac.jp
Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid
bodies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Rodríguez, E Pericuesta… - International journal …, 2007 - dialnet.unirioja.es
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

[PDF][PDF] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA RAMÍREZ, EVA PERICUESTA… - Int. J. Dev …, 2007 - scholar.archive.org
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramírez, E Pericuesta… - The International …, 2007 - pubmed.ncbi.nlm.nih.gov
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

[引用][C] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramirez, E Pericuesta, R Fernandez-Gonzalez… - 2007 - growkudos.com
Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid
bodies This shareable PDF can be hosted on any platform or network and is fully compliant …